Frustrated Covid Test-Seekers Are Overwhelming Emergency Rooms
(Bloomberg) -- As emergency rooms struggle to keep up with the omicron variant, they're also contending with a stream of frustrated people looking for Covid tests.
With retailers short of at-home tests and wait times at many urgent care centers and doctor's offices stretching for hours, those with mild or even non-existent virus symptoms have slammed ERs looking for anywhere that might have a test.
“A lot of people are pretty frustrated at long lines at testing centers. I get that. But they are coming to the ER and adding to the fray,” said Melisa Lai-Becker, an emergency physician and head of the emergency department at CHA Everett Hospital in Massachusetts.
Last Wednesday, Lai-Becker said, the hospital calculated that about 40% of its ER patients were there primarily for a Covid test. The hospital was already inundated with seriously ill Covid patients as the ultra-contagious omicron variant has led to hundreds of thousands of new cases in the U.S. each day. CHA Everett is currently handling about double the normal patient load with less than 80% the usual staff due to workers staying home after contracting the virus or being exposed to it.
‘Sky High'
“Our positivity rate is sky high,” Lai-Becker said. “And if you didn't have Covid before you came, you might be picking it up sitting in our waiting room.”
In Massachusetts on Monday, two groups representing state ER doctors and nurses put out a joint statement urging patients to not visit ERs for routine testing, pleading that ERs are at a “breaking point.” On Tuesday, Maryland Governor Larry Hogan said the state would establish more testing sites away from hospitals to divert people from going to slammed ERs for tests. And in New York City, the fire department turned to Twitter to ask New Yorkers to refrain from calling ambulances for a Covid test.
With case numbers in the U.S. reaching pandemic records in the aftermath of the holiday travel season, already-strapped rapid testing supplies have become even more scarce. Bottlenecks in the test authorization process, along with demand that's outpacing supply, have made rapid at-home tests difficult to find. As a result, those who have been exposed to the virus or who are showing mild symptoms are skipping the normal testing channels.
The Biden administration has pledged to rapidly increase supply of at-home tests, and test-makers have said they are prepared to make more tests available. But in the meantime, health care providers are urging people with mild or no symptoms to stay home and isolate if tests are not readily available.
Mount Sinai Health System in New York City said it saw an increase in people visiting emergency departments for Covid tests beginning before the holidays as people prepared to gather with friends and family. The system has expanded testing in other outpatient settings in order to meet demand.
‘Past Capacity'
In upstate New York, Keith Grams, the chair of emergency medicine at the Rochester Regional hospital system, said that the droves of patients coming to ERs each day are the least of his worries.
“They gum up the system, but they are the easiest to take care of,” he said. “Right now, we are way past capacity for people waiting for a hospital bed.”
Even as the majority of people experience milder symptoms with omicron, the sheer number of positive tests means that critical cases are rising, too. At one Rochester Regional hospital, 83 patients are currently waiting for a bed, Grams said.
“We are using every nook and cranny,” he said. If patients aren't experiencing an emergency, Grams said they should probably skip a visit to the ER. “Anytime someone doesn't have severe symptoms, the emergency department is not the best place for them.”
©2022 Bloomberg L.P.
-
India's Troika Of Good Luck | Joining The Dots
A weaker Trump, a cooling AI trade and resilient earnings have put Indian markets back in favour. Rising inflation could spoil the party.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.